- Sections
- A - Nécessités courantes de la vie
- A61P - Activité thérapeutique spécifique de composés chimiques ou de préparations médicinales
- A61P 37/04 - Immunostimulants
Détention brevets de la classe A61P 37/04
Brevets de cette classe: 6341
Historique des publications depuis 10 ans
|
233
|
299
|
358
|
372
|
509
|
551
|
501
|
631
|
602
|
375
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1602 |
62 |
| The Trustees of the University of Pennsylvania | 4415 |
60 |
| The Regents of the University of California | 20745 |
59 |
| Osaka University | 3267 |
45 |
| The University of British Columbia | 1538 |
39 |
| National Research Council of Canada | 1551 |
38 |
| University of Saskatchewan | 487 |
37 |
| The Governors of the University of Alberta | 875 |
36 |
| Bristol-myers Squibb Company | 4742 |
34 |
| Universite de Montreal | 349 |
33 |
| The University of Tokyo | 4361 |
31 |
| Pfizer Inc. | 3386 |
30 |
| Toray Industries, Inc. | 7113 |
30 |
| Nestec S.A. | 2557 |
29 |
| Memorial Sloan-Kettering Cancer Center | 2043 |
28 |
| President and Fellows of Harvard College | 6094 |
27 |
| Zoetis Services LLC | 1547 |
27 |
| Kyoto University | 2904 |
26 |
| Merck Sharp & Dohme LLC | 3734 |
25 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
24 |
| Autres propriétaires | 5621 |